Document ID: chunk:federal_register_of_legislation:C2024C00495:front:0:p2
Version: federal_register_of_legislation:C2024C00495
Segment Type: other
Provision Reference: 
Character Range: 2726–6202

chemicals
Division 1—Simplified outline of this Part
23 Simplified outline of this Part
Division 2—Introduction categories
24 Introductions must be authorised
25 Listed introductions
26 Exempted introductions
27 Reported introductions
28 Assessed introductions
29 Commercial evaluation introductions
30 Exceptional circumstances introductions
Division 3—Assessment certificates
Subdivision A—Obtaining a certificate
31 Applying for a certificate
32 Executive Director must consider application
33 Executive Director may request further information
34 Consultation with prescribed bodies
35 Consultation with Gene Technology Regulator
36 Submissions on draft assessment statement
37 Issue of certificate and assessment statement
38 Content of certificate
39 When certificate is in force
Subdivision B—Changes to certificate holders or persons covered by a certificate
40 Applying to change persons covered
41 Applying to change certificate holders
42 Changing certificate holders on Executive Director's initiative
Subdivision C—Varying the terms of an assessment certificate
43 Applying for a variation of the terms of an assessment certificate
44 Executive Director must consider application
45 Executive Director may request further information
46 Consultation with prescribed bodies
47 Consultation with Gene Technology Regulator
48 Submissions on draft assessment statement
49 Issue of varied assessment certificate and assessment statement
50 Variations on Executive Director's initiative
Subdivision D—Cancelling an assessment certificate
51 Applying to cancel a certificate
52 Cancelling on Executive Director's initiative
Division 4—Commercial evaluation authorisations
Subdivision A—Obtaining an authorisation
53 Applying for an authorisation
54 Executive Director must consider application
55 Executive Director may request further information
56 Consultation with prescribed bodies
57 Consultation with Gene Technology Regulator
58 Issue of authorisation
59 Content of authorisation
Subdivision B—Changing authorisation holders
60 Applying to change authorisation holders
61 Changing authorisation holders on Executive Director's initiative
Subdivision C—Varying the terms of an authorisation
62 Applying for a variation of the terms of an authorisation
63 Issue of varied authorisation
64 Variations on Executive Director's initiative
Subdivision D—Cancelling an authorisation
65 Applying to cancel an authorisation
66 Cancelling on Executive Director's initiative
Division 5—Exceptional circumstances authorisations
67 Exceptional circumstances authorisations
Part 4—Evaluations initiated by Executive Director
Division 1—Simplified outline of this Part
68 Simplified outline of this Part
Division 2—Evaluations of introductions authorised by an assessment certificate
69 Executive Director may initiate evaluation
70 Executive Director may require information
71 Consultation with prescribed bodies
72 Submissions on draft evaluation statement
73 Issue of evaluation statement
Division 3—Evaluations of other introductions or matters
74 Executive Director may initiate evaluation
75 Consultation to inform evaluation
76 Executive Director may require information
77 Person must comply with requirement to provide information
78 Issue of evaluation statement
Part 5—Australian Inventory of Industrial Chemicals
Division 1—Simplified outline of this Part
79 Simplified outline of this Part
Division 2—Establishment and contents of Inventory
80 Establishment of the